Cargando…

Long-Term Outcomes of Peripheral Blood Mononuclear Cells in the Treatment of Angiitis-Induced No-Option Critical Limb-Threatening Ischemia

Background: Peripheral blood mononuclear cells (PBMNCs) showed encouraging short outcomes in the treatment of angiitis-induced no-option critical limb-threatening ischemia (AICLTI) in the pilot study. This study aimed to demonstrate the long-term outcomes of this treatment. Methods: From May 2014 to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Xiaolang, Liu, Hao, Pan, Tianyue, Gu, Shiyang, Fang, Yuan, Wei, Zheng, Fang, Gang, Chen, Bin, Jiang, Junhao, Shi, Yun, Liu, Peng, Fu, Weiguo, Dong, Zhihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687358/ https://www.ncbi.nlm.nih.gov/pubmed/34938786 http://dx.doi.org/10.3389/fcvm.2021.769472

Ejemplares similares

Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experience
por: Fang, Gang, et al.
Publicado: (2020)

Autologous Stem Cells Transplantation for No-Option Angiitis-Induced Critical Limb Ischemia: Recurrence and New Lesion
por: Liu, Hao, et al.
Publicado: (2022)

Three‐year outcomes of peripheral blood mononuclear cells vs purified CD34 (+) cells in the treatment of angiitis‐induced no‐option critical limb ischemia and a cost‐effectiveness assessment: A randomized single‐blinded noninferiority trial
por: Liu, Hao, et al.
Publicado: (2021)

The peripheral blood mononuclear cells versus purified CD34(+) cells transplantation in patients with angiitis-induced critical limb ischemia trial: 5-year outcomes and return to work analysis—a randomized single-blinded non-inferiority trial
por: Liu, Hao, et al.
Publicado: (2022)

A Five‐Year Study of the Efficacy of Purified CD34+ Cell Therapy for Angiitis‐Induced No‐Option Critical Limb Ischemia
por: Fang, Yuan, et al.
Publicado: (2018)

Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia
por: Pan, Tianyue, et al.
Publicado: (2019)

Return to work after cell transplantation in patients with angiitis-induced critical limb ischaemia and factors related: a single-centre retrospective cohort study
por: Liu, Hao, et al.
Publicado: (2022)

Purified CD34(+) cells versus peripheral blood mononuclear cells in the treatment of angiitis-induced no-option critical limb ischaemia: 12-Month results of a prospective randomised single-blinded non-inferiority trial
por: Dong, Zhihui, et al.
Publicado: (2018)

Prediction of 2-Year Major Adverse Limb Event-Free Survival After Percutaneous Transluminal Angioplasty and Stenting for Lower Limb Atherosclerosis Obliterans: A Machine Learning-Based Study
por: Pan, Tianyue, et al.
Publicado: (2022)

Bmal1 Downregulation Worsens Critical Limb Ischemia by Promoting Inflammation and Impairing Angiogenesis
por: Xu, Lirong, et al.
Publicado: (2021)

Autologous Peripheral Blood Mononuclear Cells for Limb Salvage in Diabetic Foot Patients with No-Option Critical Limb Ischemia
por: Scatena, Alessia, et al.
Publicado: (2021)

Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers
por: Panunzi, Andrea, et al.
Publicado: (2022)

Stakeholder Values and Preferences in Lower Limb Amputation for No-Option Chronic Limb Threatening Ischemia
por: Nieuwstraten, Jelle A, et al.
Publicado: (2021)

Single-Cell Sequencing of Immune Cells in Human Aortic Dissection Tissue Provides Insights Into Immune Cell Heterogeneity
por: Liu, Yifan, et al.
Publicado: (2022)

Precision Medicine Enables More TNM-Like Staging in Patients With Chronic Limb Threatening Ischemia
por: McGinigle, Katharine L., et al.
Publicado: (2021)

Subunits of C1Q Are Associated With the Progression of Intermittent Claudication to Chronic Limb-Threatening Ischemia
por: Yao, Ziping, et al.
Publicado: (2022)

Comparison between endovascular aneurysm repair-selected and endovascular aneurysm repair-only strategies for the management of ruptured abdominal aortic aneurysms: An 11-year experience at a Chinese tertiary hospital
por: Fang, Gang, et al.
Publicado: (2022)

Mesenchymal stem cell-based therapy for non-healing wounds due to chronic limb-threatening ischemia: A review of preclinical and clinical studies
por: Huerta, Carlos Theodore, et al.
Publicado: (2023)

Long‐Term Outcomes of Chronic Type B Aortic Dissection Treated by Thoracic Endovascular Aortic Repair
por: Jiang, Xiaolang, et al.
Publicado: (2022)

Percutaneous deep vein arterialization: An emerging technique for no‐option chronic limb‐threatening ischemia patients
por: N'Dandu, Zola, et al.
Publicado: (2020)

Rheocarna(®) as an alternative therapeutic option for patients with chronic limb-threatening ischemia: A case report
por: Satake, Akinori, et al.
Publicado: (2023)

Serum Metabolic Signatures of Chronic Limb-Threatening Ischemia in Patients with Peripheral Artery Disease
por: Azab, Sandi M., et al.
Publicado: (2020)

Chronic Limb-Threatening Ischemia and the Need for Revascularization
por: Berchiolli, Raffaella, et al.
Publicado: (2023)

The Role of Endovascular Procedure for Peripheral Arterial Disease in Diabetic Patients With Chronic Limb-Threatening Ischemia
por: Santosa, Yudistira, et al.
Publicado: (2022)

Simultaneous Hybrid Treatment of Multilevel Peripheral Arterial Disease in Patients with Chronic Limb-Threatening Ischemia
por: Pecoraro, Felice, et al.
Publicado: (2021)

Off-the-shelf percutaneous deep vein arterialization for no-option chronic limb-threatening ischemia related to Buerger disease
por: Smith, Justin A., et al.
Publicado: (2023)

Pain Management in People with Diabetes-Related Chronic Limb-Threatening Ischemia
por: Jiang, Xiaoyan, et al.
Publicado: (2021)

A misplaced intramuscular injection and limb-threatening ischemia
por: Sarkar, Sumantra, et al.
Publicado: (2017)

The Impact of Chronic Limb-Threatening Ischemia on Cardiac Surgery
por: Wakabayashi, Naohiro, et al.
Publicado: (2022)

Novel culture media enhances mononuclear cells from patients with chronic limb-threatening ischemia to increase vasculogenesis and anti-inflammatory effect
por: Chruewkamlow, Nuttapol, et al.
Publicado: (2021)

Characterization of Mesenchymal Stem Cells of “No-Options” Patients with Critical Limb Ischemia Treated by Autologous Bone Marrow Mononuclear Cells
por: Altaner, Cestmir, et al.
Publicado: (2013)

Cutaneous Angiitis
por: Copeman, P. W. M.
Publicado: (1975)

Peripheral Blood Mononuclear Cells: A New Frontier in the Management of Patients with Diabetes and No-Option Critical Limb Ischaemia
por: Meloni, Marco, et al.
Publicado: (2023)

Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-derived Mononuclear Cell Implantation in Patients with No-option Critical Limb Ischemia
por: Yanishi, Kenji, et al.
Publicado: (2020)

MicroRNA Profile of Patients with Chronic Limb-Threatening Ischemia
por: Syed, Muzammil H., et al.
Publicado: (2020)

Therapeutic Biomaterial Approaches to Alleviate Chronic Limb Threatening Ischemia
por: Marsico, Grazia, et al.
Publicado: (2021)

Excimer laser ablation combined with drug-coated balloon versus drug-coated balloon in the treatment of de novo atherosclerotic lesions in lower extremities (ELABORATE): study protocol for a real-world clinical trial
por: Jiang, Xiaolang, et al.
Publicado: (2022)

Thrombo-Angiitis Obliterans
por: Chakravarti, D. C.
Publicado: (1935)

Case report: Endovascular treatment of acute limb ischemia in an adolescent with newly diagnosed lupus
por: Liu, Lu-Hang, et al.
Publicado: (2023)

A Tryptophan Metabolite of the Microbiota Improves Neovascularization in Diabetic Limb Ischemia
por: Ma, Xiurui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cmoj050dg5bt337aacku7pb8rk